PubRank

Karin Tarte

Author PubWeight™ 36.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2003 2.82
2 Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 2010 2.15
3 Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol 2003 1.76
4 A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. Blood 2014 1.68
5 Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2006 1.58
6 Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002 1.53
7 Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 2013 1.52
8 Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J Immunol 2011 1.42
9 Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy 2013 1.27
10 Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev 2013 1.26
11 CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. J Immunol 2009 1.24
12 Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 2012 1.16
13 CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J Immunol 2008 1.15
14 Microarray-based understanding of normal and malignant plasma cells. Immunol Rev 2006 1.12
15 Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev 2013 1.08
16 Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood 2012 1.06
17 Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application. Stem Cell Res Ther 2013 1.03
18 Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. J Infect Dis 2010 1.02
19 Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. Cancer Res 2009 0.99
20 B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro. Exp Hematol 2007 0.95
21 IL-2 requirement for human plasma cell generation: coupling differentiation and proliferation by enhancing MAPK-ERK signaling. J Immunol 2012 0.95
22 Stromal cell contribution to human follicular lymphoma pathogenesis. Front Immunol 2012 0.91
23 Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol 2006 0.87
24 Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. J Clin Invest 2014 0.85
25 Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties. Cytotherapy 2011 0.84
26 Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis. Innate Immun 2013 0.79
27 ROQUIN/RC3H1 alterations are not found in angioimmunoblastic T-cell lymphoma. PLoS One 2013 0.79
28 Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin. Tissue Eng Part A 2014 0.78
29 Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells. Haematologica 2012 0.78
30 Immune Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass: Beneficial Effects of Maintaining Mechanical Ventilation. Shock 2015 0.77
31 The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment. Stem Cells Dev 2014 0.77
32 [Immunosuppression and mesenchymal stem cells: back to the future]. Med Sci (Paris) 2011 0.76
33 Flow cytometric detection and isolation of human tonsil or lymph node T follicular helper cells. Methods Mol Biol 2015 0.75
34 Q&A with Karin Tarte, winner of the EFIS-EJI Ita Askonas Award 2015. Eur J Immunol 2015 0.75